Skip to content

Clinical trials

Observational Hematologic Neoplasms trials

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Hematologic Neoplasms Phase: Observational Clear all

332 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20012
20021
20032
20043
20053
20065
20074
20082
20094
20105
20116
20127
201312
201410
201515
201615
201712
201814
201920
202039
202138
202227
202320
202413
202519
202627

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed119
Recruiting78
Unknown status52
Active, not recruiting25
Not yet recruiting20
Terminated13
Enrolling by invitation13
Withdrawn11
Suspended1

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
M.D. Anderson Cancer Center30
St. Jude Children's Research Hospital10
University of California, San Francisco8
Assistance Publique - Hôpitaux de Paris7
National Cancer Institute (NCI)7
Assiut University6
City of Hope Medical Center6
Mayo Clinic5
National Heart, Lung, and Blood Institute (NHLBI)5
Center for International Blood and Marrow Transplant Research4

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Hematologic Neoplasms332
Neoplasms42
Lymphoma30
Leukemia28
Multiple Myeloma27
Leukemia, Myeloid, Acute26
COVID-1918
Precursor Cell Lymphoblastic Leukemia-Lymphoma17
Myelodysplastic Syndromes14
Leukemia, Lymphocytic, Chronic, B-Cell13

Trials

Showing 26 to 50 of 332. Each trial links to its page on Pharma Observatory.

232 more trials match. See them on Pharma Observatory

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.